within Pharmacolibrary.Drugs.C_CardiovascularSystem.C01C_CardiacStimulantsExclCardiacGlycosides.C01CX08_Levosimendan;

model Levosimendan
  extends Pharmacolibrary.Drugs.ATC.C.C01CX08;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C01CX08</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Levosimendan is a calcium sensitizer and potassium channel opener used for short-term treatment of acute decompensated severe chronic heart failure in adults. It enhances myocardial contractility without increasing myocardial oxygen demand. It is approved in various countries but not in the United States.</p><h4>Pharmacokinetics</h4><p>Population pharmacokinetics in adult patients with severe heart failure following intravenous administration.</p><h4>References</h4><ol><li><p>Puttonen, J, et al., &amp; Pentikäinen, PJ (2008). Pharmacokinetics of intravenous levosimendan and its metabolites in subjects with hepatic impairment. <i>Journal of clinical pharmacology</i> 48(4) 445–454. DOI:<a href=&quot;https://doi.org/10.1177/0091270007313390&quot;>10.1177/0091270007313390</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18303124/&quot;>https://pubmed.ncbi.nlm.nih.gov/18303124</a></p></li><li><p>Grześk, G, et al., &amp; Dobosiewicz, M (2022). The importance of pharmacokinetics, pharmacodynamic and repetitive use of levosimendan. <i>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</i> 153 113391–None. DOI:<a href=&quot;https://doi.org/10.1016/j.biopha.2022.113391&quot;>10.1016/j.biopha.2022.113391</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36076524/&quot;>https://pubmed.ncbi.nlm.nih.gov/36076524</a></p></li><li><p>Figgitt, DP, et al., &amp; Goa, KL (2001). Levosimendan. <i>Drugs</i> 61(5) 613–629. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200161050-00006&quot;>10.2165/00003495-200161050-00006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11368286/&quot;>https://pubmed.ncbi.nlm.nih.gov/11368286</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Levosimendan;
